[{"from": "human", "value": "Provide a description of this molecule. [C][C@@H1][Branch2][=Branch1][C][C][=C][C][=C][N][C][Ring1][=Branch1][=N][C][=Branch1][Ring2][=C][Ring1][Branch1][C][=C][C][=C][Branch1][Branch1][C][=C][Ring1][=Branch1][C][C@@H1][Branch1][=N][C][N][C][=Branch1][C][=O][C][N][Branch1][C][C][C][N][C][=Branch1][C][=O][C][=C][C][=Branch1][=C][=C][Branch1][Branch1][C][=C][Ring1][=Branch1][O][C][Branch1][C][C][C][Cl][O]"}, {"from": "gpt", "value": "The molecule is a small-molecule inhibitor of the mitotic kinesin centromere-associated protein E (CENP-E), with potential antineoplastic activity. Upon administration, GSK-923295A binds to and inhibits CENP-E, thereby preventing cell division, inducing cell cycle arrest, and ultimately leading to an inhibition of cell proliferation. CENP-E, a kinetochore-associated mitotic kinesin, plays an essential role in chromosome movement during mitosis and regulates cell-cycle transition from metaphase to anaphase."}]